HomePTGX • NASDAQ
Protagonist Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 4.71M | 0.79% |
Operating expense | 51.13M | 10.85% |
Net income | -39.34M | -18.46% |
Net profit margin | -834.87 | -17.53% |
Earnings per share | -0.62 | -14.81% |
EBITDA | -46.06M | -11.74% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 576.12M | 22.91% |
Total assets | 701.69M | 16.20% |
Total liabilities | 56.25M | -21.81% |
Total equity | 645.44M | — |
Shares outstanding | 62.52M | — |
Price to book | 8.16 | — |
Return on assets | -16.35% | — |
Return on capital | -17.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -39.34M | -18.46% |
Cash from operations | -1.94M | 93.05% |
Cash from investing | -58.56M | 71.94% |
Cash from financing | 5.66M | -53.04% |
Net change in cash | -54.83M | 75.58% |
Free cash flow | 13.06M | 193.04% |
Previous close
$84.39
Day range
$84.45 - $86.28
Year range
$33.70 - $93.25
Market cap
5.36B USD
Avg Volume
1.36M
P/E ratio
136.58
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
128
